Epstein-Barr virus and lymphoproliferation in methotrexate-treated rheumatoid arthritis

Modern Pathology

Volumn 9, Issue 3, 1996, Pages 261-266

  Thomason, Ronald W ^b   Craig, Fiona E ^b   Banks, Peter M ^b   Sears, Donald L ^b   Myerson, Gary E ^b   Gulley, Margaret L ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b NONE

Author keywords

Epstein Barr virus; Lymphoma; Methotrexate; Post transplantation lymphoproliferative disorder; Rheumatoid arthritis

Indexed keywords

METHOTREXATE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOPROLIFERATIVE DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; BLOTTING, SOUTHERN; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOPROLIFERATIVE DISORDERS; METHOTREXATE; MIDDLE AGED;

EID: 0029978408     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. List AF, Greco FA, Vogler LB: Lymphoproliferative diseases in immunocompromised hosts: The role of Epstein-Barr virus. J Clin Oncol 5:1673, 1987.
2. Bieme JJ: Malignant lymphomas associated with immunodeficiency states. Ann Clin Lab Sci 20:175, 1990.
3. Brusamolino E, Pagnucco G, Bernasconi C: Secondary lymphomas: A review of lymphoproliferative diseases arising in immunocompromised hosts. Prevalence, clinical features and pathogenetic mechanisms. Haematologica 74:605, 1989.
4. Knowles DM, Chamulak GA, Subar M, et al.: Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 108:744, 1988.
5. Starzl TE, Nalesnik MA, Porter KA, et al.: Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1:583, 1984.
6. Nalesnik MA, Makowka L, Starzl TE: The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Probl Surg 25:367, 1988.
7. First MR: Transplantation in the nineties. Transplantation 53:1, 1992.
8. Penn I: Cancers following cyclosporin therapy. Transplant Proc 19:2211, 1987.
9. Craig FE, Gulley ML, Banks PM: Post-transplantation lymphoproliferative disorders. Am J Clin Pathol 99:265, 1993.
10. Kamel OW, Matthijs RIJN, LeBrun DP, et al.: Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: Frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 25:638, 1994.
11. Kamel OW, Matthijs RIJN, Weiss LM, et al.: Brief report: Reversible lymphomas associated with Epstein-Barr virus occurring during therapy for rheumatoid arthritis and dermatomyositis. N Eng J Med 328:1317, 1993.
12. Elias JM, Margiotta M, Gaborc O: Sensitivity and detection efficiency of the peroxidase antiperoxidase (PAP), avidin-biotin peroxidase complex (ABC) and peroxidase-labeled avidin-biotin (LAB) methods. Am J Clin Pathol 92:62, 1989.
13. Rowe M, Evans H, Young L, et al.: Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression on virus-transformed cells. J Gen Virol 68:1575, 1987.
14. Pallesen G, Hamilton-Dutoit SJ, Rowe M, et al.: Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphomas. J Pathol 165:289, 1991.
15. Gulley ML, Eagan PA, Quintanilla-Martinez L, et al.: Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: Association with mixed cellularity subtype and Hispanic American ethnicity. Blood 84:1595, 1994.
16. Andersen J, Zieve GW: Assembly and intracellular transport of snRNP particles. Bioessays 14:57, 1991.
17. Raab-Traub N, Flynn K: The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883, 1986.
18. Swerdlow SH: Post-transplant lymphoproliferative disorders: A morphologic, phenotypic and genotypic spectrum of disease. Histopathology 20:373, 1992.
19. Nalesnik MA, Jaffe R, Starzl TE, et al.: The pathology of posttransplant lymphoproliferation disorders occurring in the setting of cyclosporin A-prednisone immunosuppression. Am J Pathol 133:173, 1988.
20. Barletta JM, Kingma DW, Ling Y, et al.: Rapid in situ hybridization for the diagnosis of latent Epstein-Barr infection. Mol Cell Probes 7:105, 1993.
21. Gilligan K, Rafadurai P, Resnick L, et al.: Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc Natl Acad Sci U S A 8:8790, 1990.
22. Howe JG, Steits JA: Localization of Epstein-Barr virus encoded small RNAs by in situ hybridization. Proc Natl Acad Sci U S A 83:9006, 1986.
23. Gulley ML, Raab-Traub N: Detection of Epstein-Barr virus in human tissues by molecular genetic techniques. Arch Pathol Lab Med 117:1115, 1993.
24. Dillner J, Kaliin B: The Epstein-Barr virus proteins. Adv Cancer Res 50:95, 1988.
25. Wang D, Liebowitz D, Kieff E: An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831, 1985.
26. Grogan E, Jenson H, Countryman J, et al.: Transfection of a rearranged viral DNA fragment, WZhet, stably converts Epstein-Barr viral infection to productive infection in lymphoid cells. Proc Natl Acad Sci U S A 84:1332, 1987.
27. Miller G: The switch between latency and replication of Epstein-Barr virus. J Infect Dis 161:833, 1990.
28. Hanto DW, Gajl-Peczalska KJ, Frizzera G, et al.: Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Ann Surg 198:356, 1983.
29. Hanto DW, Frizzera G, Gajl-Peczalska KJ, et al.: Epstein-Barr virus, immunodeficiency, and B-cell lymphoproliferation. Transplantation 39:461, 1985.
30. Saemundsen AK, Purtilo DT, Sakamoto K, et al.: Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative disease by Epstein-Barr virus complimentary RNA/DNA and viral DNA/DNA hybridization. Cancer Res 41:4237, 1981.
31. Purtilo DT, Tatsumi E, Manolov G, et al: Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and proliferative diseases in immune deficient patients. Int Rev Exp Pathol 27:113, 1985.
32. Ho M, Jaffe R, Miller G, et al.: The frequency of EBV infection and associated lymphoproliferative syndrome after transplantation and manifestations in children. Transplantation 45:719, 1988.
33. Katz BZ, Raab-Traub N, Miller G: Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. J Infect Dis 160:589, 1989.
34. Weiss LM, Movahed LA: In situ demonstration of Epstein-Barr viral genomes in viral-associated B cell lymphoproliferations. Am J Pathol 134:651, 1989.
35. Hanto DW, Frizzera G, Partilo DT, et al.: Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 41:4253, 1981.
36. Thomas JA, Hotchin MA, Allday MJ, et al.: Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation 49:944, 1990.
37. Kaplan MA, Ferry JA, Harris NL, et al.: Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers. Am I Clin Pathol 101:590, 1994.
38. Cleary ML, Warnke R, Sklar J: Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients: Clonal analysis based on immunoglobulin-gene rearrangements. N Eng J Med 310:477, 1984.
39. Locker J, Nalesnik M: Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol 135:977, 1989.
40. Gulley ML, Raphael M, Lutz CT, et al.: Epstein-Barr virus integration in human lymphomas and lymphoid cell lines. Cancer 70:185, 1992.